PIPA5120698
SARS-CoV-2 NSP2 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5120698-Each-of-1 | In Stock | ₹ 43,079.46 |
PIPA5120698 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 43,079.46
GST (18%): ₹ 7,754.303
Total Price: ₹ 50,833.763
Antigen
SARS-CoV-2 NSP2
Classification
Polyclonal
Conjugate
Unconjugated
Gene Alias
CoV; CoV-2; NSP2; SARS
Immunogen
A synthetic peptide corresponding to a sequence within amino acids 150-250 of coronavirus NSP2 (YP_0097426091)
Quantity
100 μL
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Applications
Western Blot
Concentration
0.861 mg/mL
Formulation
PBS with 50% glycerol and 0.01% thimerosal; pH 7.3
Host Species
Rabbit
Purification Method
Affinity Chromatography
Regulatory Status
RUO
Target Species
Virus
Product Type
Antibody
Isotype
IgG
Description
- Positive test controls include: 293T
- Immunogen sequence: SWQTGDFVKA TCEFCGTENL TKEGATTCGY LPQNAVVKIY CPACHNSEVG PEHSLAEYHN ESGLKTILRK GGRTIAFGGC VFSYVGCHNK CAYWVPRASA N Severe Acute Respiratory Syndrome (SARS), an emerging disease characterized by atypical pneumonia, has recently been attributed to a novel coronavirus (SARS-CoV)
- The nucleocapsid protein (N) was one of the structural proteins of SARS-CoV (N, S, sE, M)
- The severe acute respiratory syndrome coronavirus (SARS-CoV) nucleocapsid (N) protein is the most abundant protein in the virus-infected cells
- The SARS-CoV-2 S gene has 76% amino acid similarity to the SARS-CoV S gene, and nonsynonymous mutations developed in the S protein as the SARS-CoV epidemic developed, reports have shown that the crystal structure of the SARS-CoV-2 nucleocapsid protein is similar to those of previously described coronavirus N proteins, but their surface electrostatic potential characteristics are distinct.
Compare Similar Items
Show Difference
Antigen: SARS-CoV-2 NSP2
Classification: Polyclonal
Conjugate: Unconjugated
Gene Alias: CoV; CoV-2; NSP2; SARS
Immunogen: A synthetic peptide corresponding to a sequence within amino acids 150-250 of coronavirus NSP2 (YP_0097426091)
Quantity: 100 μL
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Applications: Western Blot
Concentration: 0.861 mg/mL
Formulation: PBS with 50% glycerol and 0.01% thimerosal; pH 7.3
Host Species: Rabbit
Purification Method: Affinity Chromatography
Regulatory Status: RUO
Target Species: Virus
Product Type: Antibody
Isotype: IgG
Antigen:
SARS-CoV-2 NSP2
Classification:
Polyclonal
Conjugate:
Unconjugated
Gene Alias:
CoV; CoV-2; NSP2; SARS
Immunogen:
A synthetic peptide corresponding to a sequence within amino acids 150-250 of coronavirus NSP2 (YP_0097426091)
Quantity:
100 μL
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Applications:
Western Blot
Concentration:
0.861 mg/mL
Formulation:
PBS with 50% glycerol and 0.01% thimerosal; pH 7.3
Host Species:
Rabbit
Purification Method:
Affinity Chromatography
Regulatory Status:
RUO
Target Species:
Virus
Product Type:
Antibody
Isotype:
IgG
Antigen: RSK1/RSK2/RSK3
Classification: Polyclonal
Conjugate: Unconjugated
Gene Alias: 90 kDa ribosomal protein S6 kinase 1; 90 kDa ribosomal protein S6 kinase 2; 90 kDa ribosomal protein S6 kinase 3; 90kDa; C130006E23; CLS; D17Wsu134e; dJ590P13.1 (ribosomal protein S6 kinase, 90kD, polypeptide 1); HU-1; HU-2; HU-3; Insulin-stimulated protein kinase 1; ISPK1; ISPK-1; MAP kinase-activated protein kinase 1; MAP kinase-activated protein kinase 1a; MAP kinase-activated protein kinase 1b; MAP kinase-activated protein kinase 1c; MAPK-activated protein kinase 1; MAPK-activated protein kinase 1a; MAPK-activated protein kinase 1b; MAPK-activated protein kinase 1c; MAPKAP kinase 1; MAPKAP kinase 1a; MAPKAP kinase 1b; MAPKAP kinase 1C; MAPKAPK-1; MAPKAPK1A; MAPKAPK-1a; MAPKAPK1B; MAPKAPK-1b; Mapkapk1c; MAPKAPK-1c; mitogen-activated protein kinase-activated protein kinase 1C; MPK-9; MRX19; p90 rsk; p90Rsk; p90-RSK; p90-RSK 1; p90-RSK 2; p90-RSK 3; p90Rsk1; p90-Rsk1; p90RSK2; p90-RSK2; p90RSK3; p90-RSK3; p90S6K; pp90rsk; pp90RSK1; pp90RSK2; pp90RSK3; protein-tyrosine kinase Mpk-9; RG
Immunogen: A synthetic peptide corresponding to a sequence within amino acids 600-700 of human RPS6KA1/RPS6KA2/RPS6KA3 (NP_002944.2).
Quantity: 100 μL
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Applications: Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot
Concentration: 2.386 mg/mL
Formulation: PBS with 50% glycerol and 0.01% thimerosal; pH 7.3
Host Species: Rabbit
Purification Method: Affinity Chromatography
Regulatory Status: RUO
Target Species: Human, Mouse, Rat
Product Type: Antibody
Isotype: IgG
Antigen:
RSK1/RSK2/RSK3
Classification:
Polyclonal
Conjugate:
Unconjugated
Gene Alias:
90 kDa ribosomal protein S6 kinase 1; 90 kDa ribosomal protein S6 kinase 2; 90 kDa ribosomal protein S6 kinase 3; 90kDa; C130006E23; CLS; D17Wsu134e; dJ590P13.1 (ribosomal protein S6 kinase, 90kD, polypeptide 1); HU-1; HU-2; HU-3; Insulin-stimulated protein kinase 1; ISPK1; ISPK-1; MAP kinase-activated protein kinase 1; MAP kinase-activated protein kinase 1a; MAP kinase-activated protein kinase 1b; MAP kinase-activated protein kinase 1c; MAPK-activated protein kinase 1; MAPK-activated protein kinase 1a; MAPK-activated protein kinase 1b; MAPK-activated protein kinase 1c; MAPKAP kinase 1; MAPKAP kinase 1a; MAPKAP kinase 1b; MAPKAP kinase 1C; MAPKAPK-1; MAPKAPK1A; MAPKAPK-1a; MAPKAPK1B; MAPKAPK-1b; Mapkapk1c; MAPKAPK-1c; mitogen-activated protein kinase-activated protein kinase 1C; MPK-9; MRX19; p90 rsk; p90Rsk; p90-RSK; p90-RSK 1; p90-RSK 2; p90-RSK 3; p90Rsk1; p90-Rsk1; p90RSK2; p90-RSK2; p90RSK3; p90-RSK3; p90S6K; pp90rsk; pp90RSK1; pp90RSK2; pp90RSK3; protein-tyrosine kinase Mpk-9; RG
Immunogen:
A synthetic peptide corresponding to a sequence within amino acids 600-700 of human RPS6KA1/RPS6KA2/RPS6KA3 (NP_002944.2).
Quantity:
100 μL
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Applications:
Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot
Concentration:
2.386 mg/mL
Formulation:
PBS with 50% glycerol and 0.01% thimerosal; pH 7.3
Host Species:
Rabbit
Purification Method:
Affinity Chromatography
Regulatory Status:
RUO
Target Species:
Human, Mouse, Rat
Product Type:
Antibody
Isotype:
IgG
Antigen: RAB11A/RAB11B
Classification: Polyclonal
Conjugate: Unconjugated
Gene Alias: A730055L17Rik; GTP-binding protein YPT3; H-YPT3; RAB 11A, member oncogene family; RAB11; rab-11; RAB11A; RAB11A, member RAS oncogene family; RAB11B; RAB11B, member of RAS oncogene family; RAB11B, member RAS oncogene family; RAS oncogene family protein; ras-related protein Rab-11A; Ras-related protein Rab-11B; YL8; YPT3
Immunogen: A synthetic peptide corresponding to a sequence within amino acids 1-100 of human RAB11A/RAB11B (NP_0046541)
Quantity: 100 μL
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Applications: Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot
Concentration: 1.507 mg/mL
Formulation: PBS with 50% glycerol and 0.01% thimerosal; pH 7.3
Host Species: Rabbit
Purification Method: Affinity Chromatography
Regulatory Status: RUO
Target Species: Human, Mouse, Rat
Product Type: Antibody
Isotype: IgG
Antigen:
RAB11A/RAB11B
Classification:
Polyclonal
Conjugate:
Unconjugated
Gene Alias:
A730055L17Rik; GTP-binding protein YPT3; H-YPT3; RAB 11A, member oncogene family; RAB11; rab-11; RAB11A; RAB11A, member RAS oncogene family; RAB11B; RAB11B, member of RAS oncogene family; RAB11B, member RAS oncogene family; RAS oncogene family protein; ras-related protein Rab-11A; Ras-related protein Rab-11B; YL8; YPT3
Immunogen:
A synthetic peptide corresponding to a sequence within amino acids 1-100 of human RAB11A/RAB11B (NP_0046541)
Quantity:
100 μL
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Applications:
Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot
Concentration:
1.507 mg/mL
Formulation:
PBS with 50% glycerol and 0.01% thimerosal; pH 7.3
Host Species:
Rabbit
Purification Method:
Affinity Chromatography
Regulatory Status:
RUO
Target Species:
Human, Mouse, Rat
Product Type:
Antibody
Isotype:
IgG
Antigen: SARS-CoV-2 ORF7a
Classification: Polyclonal
Conjugate: Unconjugated
Gene Alias: COVID19 ORF7a
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 16-98 of coronavirus ORF7a (YP_0097243951)
Quantity: 100 μL
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Applications: Western Blot
Concentration: 1.15 mg/mL
Formulation: PBS with 50% glycerol and 0.01% thimerosal; pH 7.3
Host Species: Rabbit
Purification Method: Affinity Chromatography
Regulatory Status: RUO
Target Species: Virus
Product Type: Antibody
Isotype: IgG
Antigen:
SARS-CoV-2 ORF7a
Classification:
Polyclonal
Conjugate:
Unconjugated
Gene Alias:
COVID19 ORF7a
Immunogen:
Recombinant fusion protein containing a sequence corresponding to amino acids 16-98 of coronavirus ORF7a (YP_0097243951)
Quantity:
100 μL
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Applications:
Western Blot
Concentration:
1.15 mg/mL
Formulation:
PBS with 50% glycerol and 0.01% thimerosal; pH 7.3
Host Species:
Rabbit
Purification Method:
Affinity Chromatography
Regulatory Status:
RUO
Target Species:
Virus
Product Type:
Antibody
Isotype:
IgG